α2-Adrenoceptor agonist induces peripheral antinociception via the endocannabinoid system

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Pharmacological Reports

• Publication date

  2020-01-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s43440-019-00053-6PMID 32016857
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Conscious Animals

  2018cited by this paper
• The Involvement of the Endocannabinoid System in the Peripheral Antinociceptive Action of Ketamine.

  2017cited by this paper
• CB1 and CB2 Cannabinoid Receptor Agonists Induce Peripheral Antinociception by Activation of the Endogenous Noradrenergic System

  2013cited by this paper
• Endogenous cannabinoid receptor agonist anandamide induces peripheral antinociception by activation of ATP-sensitive K+ channels.

  2011cited by this paper
• Adrenergic Signaling in Human Oral Keratinocytes and Wound Repair

  2011cited by this paper
• Anti-Inflammatory Properties of CB1-Receptor Antagonist Involves β2 Adrenoceptors

  2010cited by this paper
• Probable involvement of alpha(2C)-adrenoceptor subtype and endogenous opioid peptides in the peripheral antinociceptive effect induced by xylazine.

  2009cited by this paper
• Targeting the endocannabinoid system: to enhance or reduce?

  2008cited by this paper
• Endocannabinoids: synthesis and degradation.

  2008cited by this paper
• The μ‐opioid receptor agonist morphine, but not agonists at δ‐ or κ‐opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors

  2008cited by this paper
• Targeting the endocannabinoid system: to enhance or reduce?

  2008cited by this paper
• Antinociceptive effect of spinally administered cannabinergic and 2-adrenoceptor drugs on the formalin test in rat: possible interactions

  2006cited by this paper
• CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.

  2005cited by this paper
• Synergistic and additive interactions of the cannabinoid agonist CP55,940 with μ opioid receptor and α2‐adrenoceptor agonists in acute pain models in mice

  2005cited by this paper
• Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue

  2004cited by this paper
• Autocrine catecholamine biosynthesis and the beta-adrenoceptor signal promote pigmentation in human epidermal melanocytes.

  2004cited by this paper
• Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners*

  2004cited by this paper
• Cannabinoid physiology and pharmacology: 30 years of progress.

  2004cited by this paper
• The Endocannabinoid System in Human Keratinocytes

  2003cited by this paper
• The Endocannabinoid System in Human Keratinocytes. Evidence that Anandamide Inhibits Epidermal Differentiation through CB1 Receptor-Dependent Inhibition of Protein Kinase C, Activating Protein-1 and Transglutaminase*

  2003cited by this paper
• Pharmacologic Interaction between Cannabinoid and either Clonidine or Neostigmine in the Rat Formalin Test

  2003cited by this paper
• CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity

  2003cited by this paper
• Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2 Cannabinoid Receptors

  2003cited by this paper
• Norepinephrine, the beta-adrenergic receptor, and immunity.

  2002cited by this paper
• CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain

  2002cited by this paper
• Norepinephrine, the β-Adrenergic Receptor, and Immunity

  2002cited by this paper
• International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

  2002cited by this paper
• Activation of Muscarinic Acetylcholine Receptors Enhances the Release of Endogenous Cannabinoids in the Hippocampus

  2002cited by this paper
• CB2 cannabinoid receptor‐mediated peripheral antinociception

  2001cited by this paper
• Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo.

  2001cited by this paper
• Beta2-adrenoceptors: mechanisms of action of beta2-agonists.

  2001cited by this paper
• Activation of ATP-sensitive K(+) channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside.

  2000cited by this paper
• Transmitters involved in antinociception in the spinal cord.

  1999cited by this paper
• Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system.

  1998cited by this paper
• &agr;2‐Adrenergic receptor subtypes in rat dorsal root and superior cervical ganglion neurons

  1997cited by this paper
• Biosynthesis, Uptake, and Degradation of Anandamide and Palmitoylethanolamide in Leukocytes*

  1997cited by this paper
• Functional role of high-affinity anandamide transport, as revealed by selective inhibition.

  1997cited by this paper
• The induction of the α‐1‐adrenoceptor signal transduction system on human melanocytes

  1996cited by this paper
• Antinociceptive actions of intrathecal xylazine: interactions with spinal cord opioid pathways.

  1996cited by this paper
• Peripheral nociceptive effects of alpha 2-adrenergic receptor agonists in the rat.

  1995cited by this paper
• Peripheral nociceptive effects of α2-adrenergic receptor agonists in the rat

  1995cited by this paper
• Molecular characterization of a peripheral receptor for cannabinoids

  1993cited by this paper
• Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatment.

  1990cited by this paper
• Xylazine antinociception in mice: evidence for mediation by postsynaptic adrenoceptors.

  1989cited by this paper
• Peripheral analgesic action of clonidine: mediation by release of endogenous enkephalin-like substances.

  1988cited by this paper
• Pathway to carrageenan-induced inflammation in the hind limb of the rat.

  1987cited by this paper
• Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing.

  1985cited by this paper
• Ethical guidelines for investigations of experimental pain in conscious animals.

  1983cited by this paper
• Studies on the antinociceptive action of α‐agonist drugs and their interactions with opioid mechanisms

  1983cited by this paper
• Down syndrome fibroblasts are hyperresponsive to beta-adrenergic stimulation.

  1981cited by this paper
• Xylazine-induced depression and its antagonism by alpha adrenergic blocking agents.

  1981cited by this paper
• The actions of some alpha-adrenoreceptor agonists and antagonists in an antinociceptive test in mice.

  1977cited by this paper
• THE ACTIONS OF SOME α‐ADRENORECEPTOR AGONISTS AND ANTAGONISTS IN AN ANTINOCICEPTIVE TEST IN MICE

  1977cited by this paper
• Antinociceptive effects of some alpha-sympathomimetic agents.

  1974cited by this paper
• Antinociceptive effects of some α-sympathomimetic agents

  1974cited by this paper
• Prostaglandins, aspirin-like drugs and analgesia.

  1972cited by this paper
• Zur Pharmakologie von 2-(2,6-Dimethylphenylamino)-4H-5,6-dihydro-1,3-thiazin (Bayer 1470), eines Hemmstoffes adrenergischer und cholinergischer Neurone

  1967cited by this paper
• [On the pharmacology of 2-(2,6-dimethylphenylamino)-4H-5,6-dihydro-1,3-thiazine (Bayer 1470), a substance inhibitory for adrenergic and cholinergic neurons].

  1967cited by this paper
• A method for measurement of analgesic activity on inflamed tissue.

  1957cited by this paper
• A method for measurement of analgesic activity on inflamed tissue.

  1957cited by this paper

• Premedication and general anesthetic agents decrease plasma concentration of the endocannabinoid anandamide in dogs.

  2025cites this paper
• Long-term application of adrenergic agonists modulates nociceptive ion channels.

  2024cites this paper
• Antinociceptive synergy in a peripheral hyperalgesia model: interplay of cannabinoidergic, adrenergic, and opioidergic systems and their antagonism

  2024cites this paper
• Collaborative action between noradrenergic and serotoninergic systems in peripheral antinociception in mice

  2024cites this paper
• INTERACTION BETWEEN THE DOPAMINERGIC AND ENDOCANNABINOID SYSTEMS PROMOTES PERIPHERAL ANTINOCICEPTION.

  2024cites this paper
• 5,6-, 8,9-, 11,12- and 14,15-Epoxyeicosatrienoic Acids (EETs) Induce Peripheral Receptor-Dependent Antinociception in PGE2-Induced Hyperalgesia in Mice

  2024influential citation
• Clinical-haemostasis assessment of anaesthesia regimens in dogs with the somatic type of pain response

  2023cites this paper
• Clinical-haemostasis assessment of anaesthesia regimens in dogs with visceral and somatic types of pain response

  2022cites this paper